Recent progress in cancer immunotherapy: Application of nano-therapeutic systems

R Ghafelehbashi, M Salehi, M Kouhi… - Journal of Drug Delivery …, 2023 - Elsevier
Cancer immunotherapy is a hopeful strategy that seeks to enhance the immune system's
capacity to detect, manage, and eradicate cancerous cells. It has shown promise in halting …

Reassessing human MHC-I genetic diversity in T cell studies

RC Slieker, DO Warmerdam, MH Vermeer… - Scientific reports, 2024 - nature.com
Abstract The Major Histocompatibility Complex class I (MHC-I) system plays a vital role in
immune responses by presenting antigens to T cells. Allele specific technologies, including …

T antigen–specific CD8+ T cells associate with PD-1 blockade response in virus-positive Merkel cell carcinoma

UK Hansen, CD Church, AMC Simões… - The Journal of …, 2024 - Am Soc Clin Investig
Merkel cell carcinoma (MCC) is a highly immunogenic skin cancer primarily induced by
Merkel cell polyomavirus, which is driven by the expression of the oncogenic T antigens (T …

Interleukin-21 as an adjuvant in cancer immunotherapy: Current advances and future directions

X Li, M Wu, J Lu, J Yu, D Chen - … et Biophysica Acta (BBA)-Reviews on …, 2024 - Elsevier
Immunotherapy has revolutionized cancer treatment. However, it's well-recognized that a
considerable proportion of patients fail to benefit from immunotherapy, and to improve …

[PDF][PDF] Reassessing Human Genetic Diversity in T Cell Studies.

F Scheeren, R Slieker, D Warmerdam, M Vermeer… - 2023 - researchgate.net
Abstract The Major Histocompatibility Complex class I (MHC-I) system plays a vital role in
immune responses by presenting antigens to T cells. Allele speci c technologies, including …

[PDF][PDF] an, Heemskerk, MHM, & Scheeren, F..(2024)

RC Slieker, DO Warmerdam… - … human MHC-I … - scholarlypublications …
Results This study conducted a comprehensive search for articles published between
August 2020 and April 2023, focusing on T-cell research related to Severe Acute …